Literature DB >> 21707705

Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling.

Vassiliki Tzelepi1, Maria Karlou, Sijin Wen, Anh Hoang, Christopher Logothetis, Patricia Troncoso, Eleni Efstathiou.   

Abstract

AIMS: The hedgehog (Hh) signalling pathway has been implicated in the pathogenesis and aggressiveness of prostate cancer through epithelial-mesenchymal interactions. The aim of this study was to elucidate the cell-type partitioned expression of the Hh pathway biomarkers in the non-neoplastic and tumour microenvironments and to correlate it with the grade and stage of prostate cancer. METHODS AND
RESULTS: Expression of the Hh pathway components (Shh, Smo, Ptch, Gli1) in the microenvironment of non-neoplastic peripheral zone (n = 119), hormone-naive primary prostate carcinoma (n = 141) and castrate-resistant bone marrow metastases (n = 53) was analysed using immunohistochemistry in tissue microarrays and bone marrow sections. Results showed that epithelial Shh, Smo and Ptch expression was up-regulated, whereas stromal Smo, Ptch, and Gli1 expression was down-regulated in prostate carcinomas compared to non-neoplastic peripheral zone tissue. Ptch expression was modulated further in high-grade and high-stage primary tumours and in bone marrow metastases. Hh signalling correlated with ki67 and vascular endothelial growth factor (VEGF) but not with CD31 expression.
CONCLUSION: Our results highlight the importance of Hh-mediated epithelial-mesenchymal interactions in the non-neoplastic prostate and imply that shifting the balance from paracrine towards autocrine signalling is important in the pathogenesis and progression of prostate carcinoma.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21707705      PMCID: PMC4934422          DOI: 10.1111/j.1365-2559.2011.03860.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  41 in total

1.  Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform.

Authors:  X H Wehrens; B Mies; M Gimona; F C Ramaekers; G J Van Eys; J V Small
Journal:  FEBS Lett       Date:  1997-04-01       Impact factor: 4.124

2.  Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1.

Authors:  P Kogerman; T Grimm; L Kogerman; D Krause; A B Undén; B Sandstedt; R Toftgård; P G Zaphiropoulos
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

3.  Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.

Authors:  Natalia A Riobo; Gwendolyn M Haines; Charles P Emerson
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 4.  Hedgehog signaling: progenitor phenotype in small-cell lung cancer.

Authors:  D Neil Watkins; David M Berman; Stephen B Baylin
Journal:  Cell Cycle       Date:  2003 May-Jun       Impact factor: 4.534

5.  Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer.

Authors:  Motoko Seto; Miki Ohta; Yoshinari Asaoka; Tsuneo Ikenoue; Motohisa Tada; Koji Miyabayashi; Dai Mohri; Yasuo Tanaka; Hideaki Ijichi; Keisuke Tateishi; Fumihiko Kanai; Takao Kawabe; Masao Omata
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

Review 6.  Hedgehog beyond medulloblastoma and basal cell carcinoma.

Authors:  Stephan Teglund; Rune Toftgård
Journal:  Biochim Biophys Acta       Date:  2010-01-18

7.  Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation.

Authors:  Marilyn L Lamm; Winnie S Catbagan; Robert J Laciak; Daniel H Barnett; Christy M Hebner; William Gaffield; David Walterhouse; Philip Iannaccone; Wade Bushman
Journal:  Dev Biol       Date:  2002-09-15       Impact factor: 3.582

8.  A critical role of Sonic Hedgehog signaling in maintaining the tumorigenicity of neuroblastoma cells.

Authors:  Ling Mao; Yuan-Peng Xia; Yu-Nan Zhou; Ruo-Lian Dai; Xue Yang; Shu-Jie Duan; Xian Qiao; Yuan-Wu Mei; Bo Hu; Hongjuan Cui
Journal:  Cancer Sci       Date:  2009-06-26       Impact factor: 6.716

9.  Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.

Authors:  Madoka Yamazaki; Kazumasa Nakamura; Yusuke Mizukami; Masaaki Ii; Junpei Sasajima; Yoshiaki Sugiyama; Tomoya Nishikawa; Yasuhiro Nakano; Nobuyuki Yanagawa; Kazuya Sato; Atsuo Maemoto; Satoshi Tanno; Toshikatsu Okumura; Hidenori Karasaki; Toru Kono; Mikihiro Fujiya; Toshifumi Ashida; Daniel C Chung; Yutaka Kohgo
Journal:  Cancer Sci       Date:  2008-04-14       Impact factor: 6.716

Review 10.  Does prostate cancer co-opt the developmental program?

Authors:  Paul C Marker
Journal:  Differentiation       Date:  2008-07       Impact factor: 3.880

View more
  18 in total

Review 1.  Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.

Authors:  Juanita L Merchant; Milena Saqui-Salces
Journal:  Cancer Treat Rev       Date:  2013-08-13       Impact factor: 12.111

Review 2.  Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.

Authors:  Yu-Ching Peng; Alexandra L Joyner
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

3.  Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.

Authors:  Ginny L Powers; Kimberly D P Hammer; Maribella Domenech; Katsiaryna Frantskevich; Rita L Malinowski; Wade Bushman; David J Beebe; Paul C Marker
Journal:  Mol Cancer Res       Date:  2014-08-22       Impact factor: 5.852

4.  Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.

Authors:  Maria Karlou; Jing-Fang Lu; Guanglin Wu; Sankar Maity; Vassiliki Tzelepi; Nora M Navone; Anh Hoang; Christopher J Logothetis; Eleni Efstathiou
Journal:  Prostate       Date:  2012-03-27       Impact factor: 4.104

Review 5.  Wnt and SHH in prostate cancer: trouble mongers occupy the TRAIL towards apoptosis.

Authors:  A A Farooqi; S Mukhtar; A M Riaz; S Waseem; S Minhaj; B A Dilawar; B A Malik; A Nawaz; S Bhatti
Journal:  Cell Prolif       Date:  2011-10-04       Impact factor: 6.831

6.  Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.

Authors:  Davide Vecchiotti; Daniela Verzella; Mauro Di Vito Nolfi; Daniel D'Andrea; Irene Flati; Barbara Di Francesco; Jessica Cornice; Edoardo Alesse; Daria Capece; Francesca Zazzeroni
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

7.  Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

Authors:  Emmanuel S Antonarakis; Elisabeth I Heath; David C Smith; Dana Rathkopf; Amanda L Blackford; Daniel C Danila; Serina King; Anja Frost; A Seun Ajiboye; Ming Zhao; Janet Mendonca; Sushant K Kachhap; Michelle A Rudek; Michael A Carducci
Journal:  Oncologist       Date:  2013-01-22

8.  The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration.

Authors:  Manuela Torres Andion Vidal; Sílvia Vanessa Lourenço; Fernando Augusto Soares; Clarissa Araújo Gurgel; Eduardo J B Studart; Ludmila de Faro Valverde; Iguaracyra Barreto de Oliveira Araújo; Eduardo Antônio Gonçalves Ramos; Flávia Caló de Aquino Xavier; Jean Nunes Dos Santos
Journal:  Tumour Biol       Date:  2016-01-21

9.  Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Authors:  Annelies Gonnissen; Sofie Isebaert; Christiaan Perneel; Chad M McKee; Filip Van Utterbeeck; Evelyne Lerut; Clare Verrill; Richard J Bryant; Steven Joniau; Ruth J Muschel; Karin Haustermans
Journal:  Am J Pathol       Date:  2018-01-12       Impact factor: 4.307

10.  Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.

Authors:  Murielle Mimeault; Satyanarayana Rachagani; Sakthivel Muniyan; Parthasarathy Seshacharyulu; Sonny L Johansson; Kaustubh Datta; Ming-Fong Lin; Surinder K Batra
Journal:  Oncotarget       Date:  2015-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.